Case Report
dIscussIon
Sterile pyuria is not an uncommon laboratory finding. It is seen in both sexes although women (13.9%) are more commonly affected than men (2.6%) due to a higher incidence of pelvic infection. [2] It can be attributed to infectious and non-infectious causes [ Table 1 ]. [3] Commonly linked conditions include sexually transmitted infections, TB, interstitial cystitis, carcinoma in situ of the bladder and prolonged antibiotic use. [4] Sterile pyuria is often encountered in medical outpatients and even in those hospitalised for an alternate cause as an incidental detection. The same was seen in our case and has been substantiated in a study, in which 15% of medical and surgical inpatients were detected to have pyuria with sterile cultures, in the absence of other evidence to suggest urinary tract infection (UTI). [5] GU-TB is an important manifestation of extrapulmonary TB. Sterile pyuria and haematuria are most often the initial presentation, [4] advanced cases presenting with calyceal destruction and hydronephrosis. Isolation of acid-fast bacilli, solid culture and bladder biopsy with histopathology is limited by poor sensitivity. Overall, urinary PCR for Mycobacterium tuberculosis remains the most rapid and sensitive (94%) diagnostic method. [6] Treatment with anti-TB therapy is mandated.
Sexually transmitted bacterial and viral infections have an estimated annual worldwide incidence of over 125 million. [7] Atypical organisms such as chlamydia, mycoplasma and ureaplasma are common causes of sterile urine culture. Gonorrhoea has also been listed as a cause of sterile pyuria as diagnosis on routine culture is often missed. The nucleic acid amplification tests are considered gold standard for diagnosis. In a study by Nasser et al., on patients with sterile pyuria, C. trachomatis was detected in 10%, U. urealyticum in 5%, M. hominis in 3% and M. genitalium in 1% using PCR technique. [8] Globally accepted treatment for C. trachomatis infection includes azithromycin (1 g orally single dose) or doxycycline (100 mg orally twice daily for 7 days). Tetracyclines were the drug of choice for the treatment of mycoplasma and ureaplasma species, hitherto studies documented a microbiological failure rate of >68% for doxycycline and macrolide resistance of 13%-33% in M. genitalium. [9] The 2015 UK National Guideline for Management of non-gonococcal urethritis suggests a prolonged azithromycin course (500 mg stat followed by 250 mg daily for next 4 days) as first line for M. genitalium. [10] An alternative regimen is the use of ofloxacin (200 mg twice daily or 400 mg once daily) for 7 days. [10] Since our patient tested positive for C. trachomatis and M. hominis, we treated her with a standard 7-day course of oral doxycycline. Follow-up PCR was negative after 6 weeks, indicating a complete response.
Rarely, genital herpes (herpes simplex virus type 2), human papillomavirus and advanced untreated human immunodeficiency virus infection are also reported as of pyuria. Fungal infections can cause pyuria in the immunocompromised (Candida, Aspergillosis, Cryptococcus) and those associated with environmental exposure to dimorphic fungi. Urine microscopy may show budding yeast or hyphae, but special fungal culture requires up to 3 weeks.
Inflammatory conditions that are causes of sterile pyuria include interstitial cystitis, analgesic nephropathy, Kawasaki's disease and systemic lupus erythematosus. Symptoms suggestive of UTI with no response to antimicrobials, negative urine cultures, presence of systemic manifestations or relevant clinical history must raise suspicion for these aetiologies.
As observed in our case, the importance of identifying these infections is that definitive therapy [ Table 2 ] with good cure rates can be instituted early, before the onset of complications such as pelvic inflammatory disease, recurrent urethritis/ cystitis, infertility and ectopic pregnancy. Non-infectious causes are cured with the management of the underlying primary pathology.
Due to its vast possible aetiologies, it can pose a diagnostic challenge and warrant detailed evaluation. Sterile pyuria has historically been considered to be suggestive of GU-TB; [1] hence samples are not routinely screened for atypical organisms in laboratories in India. Our case underscores the importance for screening for these infections in asymptomatic individuals who serve as reservoirs. Resolution of symptoms, Proton pump inhibitors GUTB: Genitourinary tuberculosis, NSAID: Non-steroidal anti-inflammatory drugs negative culture or a negative PCR assay can be considered to define successful treatment, as pyuria may outlast the infection due to local inflammatory changes. To conclude, this case is to sensitise the physicians to this 'common, but forgotten entity'.
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